QT Imaging Holdings, Inc. (Nasdaq: QTIH) is a medical technology company that develops quantitative transmission ultrasound imaging systems, with its flagship platform targeting breast imaging and cancer detection as an alternative to conventional mammography. The company reached the public markets through a SPAC business combination, operating in the medical devices and diagnostics sector. On August 12, 2026, QTIH filed an 8-K with the Securities and Exchange Commission — accession number 0001628280-26-056179 — marking continued disclosure activity as a reporting issuer. Based in the United States, QT Imaging remains an active publicly traded entity. For full filing history, deal terms, and real-time SPAC analytics on QTIH, sign up for a free SpacDesk account at spacdesk.com.